Search Tag: Kevin Thornal
2023 19 Apr
Company Announces Preliminary, Unaudited Worldwide Revenue for First Quarter of 2023 of $96.3 Million and Reaffirms Full-Year 2023 Revenue and Non-GAAP Adjusted EBITDA Guidance Nevro Corp., a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain announced that Kevin Thornal has...Read more
2020 05 Feb
New products offer increased flexibility and efficiency for low- to high-volume molecular testing laboratories New product offerings within the Panther Scalable Solutions (PSS) portfolio are now commercially available in the United States and Europe, Hologic announced today. These new optional configurations, which represent Hologic’s next...Read more
2017 30 Sep
Patients in Clinical Studies Report 100% Satisfaction Rate Hologic, Inc. has announced that the U.S. Food and Drug Administration (FDA) has granted an expanded FDA 510(k) clearance for Cynosure's non-invasive body contouring product, SculpSure ®. The state-of-the-art body contouring laser treatment is now cleared to treat a double chin (also...Read more